[Skip to Content]
[Skip to Content Landing]
Article
April 27, 1994

Rates of Prescribing Zidovudine Post Concorde Trial

Author Affiliations

St Paul's Hospital Vancouver, British Columbia

JAMA. 1994;271(16):1239. doi:10.1001/jama.1994.03510400025020
Abstract

To the Editor.  —We conducted the present analysis to assess the impact of the publication1 of the preliminary analysis of the Concorde Trial2 and its associated publicity3,4 on zidovudine utilization in the province of British Columbia. The distribution of antiretroviral drugs in British Columbia is free of charge through the provincial Centre for Excellence in HIV/AIDS [human immunodeficiency virus/acquired immunodeficiency syndrome]. In order for physicians to prescribe zidovudine, they complete a patient enrollment form that serves as the drug prescription. This application is usually accompanied by a CD4 cell count determination. Individuals infected with HIV are eligible to receive zidovudine from this program if they have at least one CD4 cell count less than 0.50 ×109/L (500/μL). There is no other legal source of zidovudine in the province.A total of 564 new zidovudine requests were received during the first 9 months of 1993. As

First Page Preview View Large
First page PDF preview
First page PDF preview
×